Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of <i>Tripterygium wilfordii</i> against Pulmonary Artery Hypertension

<div>The results of SPR experiment. (a) Kaempferol combined with CASP3 protein. (b) Triptolide combined with PARP1 protein.</div>

Evidence-Based Complementary and Alternative Medicine

fig10

Figure 10

Figure 10: Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of <i>Tripterygium wilfordii</i> against Pulmonary Artery Hypertension 

Figure 10 | Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of Tripterygium wilfordii against Pulmonary Artery Hypertension 